Apply For Grant Funding
NeoAdjuvant Equity and Outcomes Research Matching Grants
Breast Cancer Canada has joined forces with AstraZeneca Canada to offer two collaborative grants focused on advancing research in new concepts to improve the equity of uptake, experience and outcomes from neo-adjuvant therapy (NACT) in early-stage breast cancer. The new partnership was been formed to drive progress in care for early-stage breast cancer patients.
The funding is available to Canadian research teams, 1 from Western Canada and 1 from Eastern Canada, who are developing novel programs to improve accessible referrals for neoadjuvant therapy in early-stage breast cancer and report on clinical and patient reported outcomes.
Two Program Research Grants Available: Each Grant will include $100,000 in Funding.
Canadian scientists and researchers are invited to submit research proposals by August 30, 2024.
Application Details: Comprehensive details and application procedures can be found here.
______
Questions can be directed to: research@breastcancerprogress.ca
Scientific Advisory Board
Breast Cancer Canada remains the only organization in Canada laser focused on breast cancer research. The projects we fund surround precision oncology set to deliver individualized treatment plans. Progress starts with the right people. The teams we leverage across Canada accelerate the transition from standard approaches for breast cancer treatment, to the new age of personalized medicine. Our ultimate goal is to match the right plan, to the right person, at the right time.
Dr. Marc Webster
Chair, Scientific Advisory Committee
Breast Cancer Research Focused in Precision Oncology
Breast Cancer Canada’s Scientific Advisory Board works as one to drive excellence in Canadian breast cancer research and leadership. How? By identifying, collaborating with, and funding groups and individuals. Specifically, those that are supporting our four pillars in precision oncology research. The pillars that bring us closer to earlier detection and better management.
Our research focuses on precision oncology that deliver individualized treatment models. The projects we fund across Canada accelerate the transition from standard approaches for breast cancer treatment, to the new age of personalized medicine.
The goal is to match the right plan to the right person at the right time.
Precision Genomics Research Pillars
Basic
Science
The purpose of basic science research is to increase the understanding of how fundamental biological processes work. The information uncovered by basic science projects lay the groundwork for all other research that follows.
Screening &
Detection
Using new technology to improve screening and detection – with better quality and less invasive test techniques than what we use now. New precision or personalized technology like genomic blood tests that identify breast cancer during screening, and machine learning that assists a clinician for more accurate breast cancer detection.
Treatment
Research where a biomarker has been identified for treatment research and development; or a targeted localized treatment discovery is in early stage of development involving a precision oncology focus.
Patient Reported Outcomes
Research on the implementation of patient reported outcomes across the spectrum of breast cancer screening and disease management. The data highlights how patients perceive health and treatment effects and how treatments impact outcomes. This shapes treatment and surgical interventions that impact many aspects of a patient’s life.
